Comparison

Human VEGF110 Protein, premium grade European Partner

Item no. VE0-H5212-500ug
Manufacturer ACROBiosystems
Amount 100 ug x 5
Quantity options 200 ug 20 ug 100 ug x 5
Category
Type Proteins Recombinant
Format Solid
Specific against Human (Homo sapiens)
Host HEK293
Conjugate/Tag Unconjugated
Purity 95%
Citations (1) Takahashi, H. and Shibuya, M., 2005, Clin Sci (Lond) 109, 227-41. (2) Neufeld, G. et al., 1999, FASEB J 13, 9-22. (3) Robinson, C.J. and Stringer, S.E., 2001, J Cell Sci 114, 853-65.
NCBI NP_001165097
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias RP1-261G23.1,MGC70609,MVCD1,VEGFA,VPF
Shipping Condition Room temperature
Available
Manufacturer - Category
Protein
Manufacturer - Conjugate / Tag
Native, Unconjugated
Shipping Temperature
RT
Storage Conditions
-20°C
Molecular Weight
12.7 kDa
Manufacturer - Format
Powder
Description
Vascular endothelial growth factor (VEGF), also known as vascular permeability factor (VPF) and VEGF-A, and is a member of the platelet-derived growth factor (PDGF)/vascular endothelial growth factor (VEGF) family and encodes a protein that is often found as a disulfide linked homodimer. This protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, and inhibiting apoptosis. Alternatively spliced transcript variants, encoding either freely secreted or cell-associated isoforms, have been characterized. Alternatively spliced isoforms of 110, 121, 145, 165, 183, 189 and 206 amino acids in length are expressed in humans.
Background
Vascular endothelial growth factor (VEGF), also known as vascular permeability factor (VPF) and VEGF-A, and is a member of the platelet-derived growth factor (PDGF)/vascular endothelial growth factor (VEGF) family and encodes a protein that is often found as a disulfide linked homodimer. This protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, and inhibiting apoptosis. Alternatively spliced transcript variants, encoding either freely secreted or cell-associated isoforms, have been characterized. Alternatively spliced isoforms of 110, 121, 145, 165, 183, 189 and 206 amino acids in length are expressed in humans.
Molecule
VEGF110
Exp Region
Ala 27 - Arg 136
Characteristics
This protein carries no "tag". The protein has a calculated MW of 12.7 kDa. The protein migrates as 16-18 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
Endotoxin
0.2 EU per μg
Buffer
PBS, pH7.4
Stability
● -20°C to -70°C for 12 months in lyophilized state
● -70°C for 3 months under sterile conditions after reconstitution._x000D_For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Protectant
trehalose

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 ug x 5
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?